Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by longterm56on Apr 21, 2019 10:00pm

211 Views

Post# 29653163

I'm Back (After Lent)

Hi all -

One of the things I gave up for Lent was daily reading of this board ... in order to remind myself that this is not the most important thing in life.

So, I'm back, and a bit disappointed by the past 6 weeks of Therf perfomance. But, it is what it is, and I'm encouraged by the news of the past 6 weeks even if the SP has not reflected it.

Happy Easter, and Peace to all ... and financial blessings if His will -

-LT

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal